S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.

Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela M Baerlocher, Jiri Mayer, Tim H Brümmendorf, Paul La Rosee, Dominik Heim, Stefan W Krause, Philipp Le Coutre, Christian Fabisch, Jenny Rinke, Thoralf Lange, Alice Fabarius, Marcel Lorch, Mathias Hänel, Frank Stegelmann, Georg-Nikolaus Franke, Markus Radsak, Volker Kunzmann, Danny Himsel, Denise Kohn, Thomas Lang, Rüdiger Hehlmann, Thomas Ernst, Markus Pfirrmann

Open source

DOI: 10.1097/01.hs9.0000967540.46956.59
Published: 8
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000967540.46956.59,
  title = {S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.},
  author = {Andreas Hochhaus and Andreas Burchert and Susanne Saußele and Gabriela M Baerlocher and Jiri Mayer and Tim H Brümmendorf and Paul La Rosee and Dominik Heim and Stefan W Krause and Philipp Le Coutre and Christian Fabisch and Jenny Rinke and Thoralf Lange and Alice Fabarius and Marcel Lorch and Mathias Hänel and Frank Stegelmann and Georg-Nikolaus Franke and Markus Radsak and Volker Kunzmann and Danny Himsel and Denise Kohn and Thomas Lang and Rüdiger Hehlmann and Thomas Ernst and Markus Pfirrmann},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000967540.46956.59},
  url = {https://doi.org/10.1097/01.hs9.0000967540.46956.59}
}

RIS

TY  - JOUR
TI  - S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
AU  - Andreas Hochhaus
AU  - Andreas Burchert
AU  - Susanne Saußele
AU  - Gabriela M Baerlocher
AU  - Jiri Mayer
AU  - Tim H Brümmendorf
AU  - Paul La Rosee
AU  - Dominik Heim
AU  - Stefan W Krause
AU  - Philipp Le Coutre
AU  - Christian Fabisch
AU  - Jenny Rinke
AU  - Thoralf Lange
AU  - Alice Fabarius
AU  - Marcel Lorch
AU  - Mathias Hänel
AU  - Frank Stegelmann
AU  - Georg-Nikolaus Franke
AU  - Markus Radsak
AU  - Volker Kunzmann
AU  - Danny Himsel
AU  - Denise Kohn
AU  - Thomas Lang
AU  - Rüdiger Hehlmann
AU  - Thomas Ernst
AU  - Markus Pfirrmann
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000967540.46956.59
UR  - https://doi.org/10.1097/01.hs9.0000967540.46956.59
ER  -

APA

Hochhaus, A., Burchert, A., Saußele, S., Baerlocher, G. M., Mayer, J., Brümmendorf, T. H., Rosee, P. L., Heim, D., Krause, S. W., Coutre, P. L., Fabisch, C., Rinke, J., Lange, T., Fabarius, A., Lorch, M., Hänel, M., Stegelmann, F., Franke, G., Radsak, M., Kunzmann, V., Himsel, D., Kohn, D., Lang, T., Hehlmann, R., Ernst, T., & Pfirrmann, M. (2023). S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.. HemaSphere. https://doi.org/10.1097/01.hs9.0000967540.46956.59

Source records

doaj · retrieved 2026-09-26T04:49:17.318Z